Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dimebon
2. Dimebone
3. Dimebolin
1. Dimebolin
2. 3613-73-8
3. Dimebon
4. Dimebone
5. Latrepirdina
6. Od9237k1z6
7. Pf-01913539
8. Dtxsid20189705
9. 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1h-pyrido(4,3-b)indole
10. 5-(2-{2,8-dimethyl-1h,2h,3h,4h,5h-pyrido[4,3-b]indol-5-yl}ethyl)-2-methylpyridine
11. Latrepirdinum
12. 5-(2-(2,8-dimethyl-1h,2h,3h,4h,5h-pyrido(4,3-b)indol-5-yl)ethyl)-2-methylpyridine
13. Refchem:798539
14. Dtxcid40112196
15. 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)-ethyl)-1h-pyrid(4,3b)indole
16. Pf1913539
17. Pf01913539
18. 2,8-dimethyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole
19. 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1h-pyrido[4,3-b]indole
20. Mfcd00387540
21. Chembl589390
22. Dimeboline
23. 2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-1h-pyrido[4,3-b]indole
24. 2,8-dimethyl-5-[2-(6-methyl-pyridin-3-yl)-ethyl]-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole
25. Preparation 84
26. 1h-pyrido[4,3-b]indole,2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-
27. C21h25n3
28. Smr001317776
29. Latrepirdine [usan]
30. Latrepirdine [usan:inn]
31. Brn 0622478
32. Unii-od9237k1z6
33. Dimebon?
34. 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole
35. Dimebolin [mi]
36. Latrepirdine (usan/inn)
37. Latrepirdine [inn]
38. Latrepirdine [mart.]
39. Mls002264475
40. Mls006013366
41. Latrepirdine [who-dd]
42. Schembl292354
43. Orb1306328
44. Latrepirdine Hydrochloride
45. Schembl29357222
46. Schembl29717625
47. Schembl29717663
48. Chebi:92976
49. Glxc-10857
50. Hms2200m23
51. Hms3327a20
52. Ex-a1498
53. Bdbm50305261
54. Akos005146217
55. Ac-5146
56. Db11725
57. 1h-pyrido(4,3-b)indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-
58. 2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-3,4-dihydro-1h-pyrido[4,3-b]indole
59. Ncgc00182554-01
60. Ncgc00182554-02
61. Ncgc00182554-04
62. As-35091
63. Hy-14862
64. Sy038470
65. Db-069323
66. Db-260452
67. Ns00070385
68. D09917
69. 613d738
70. Q408580
71. Brd-k55703048-001-07-7
72. Brd-k55703048-300-01-6
73. 2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole
74. 9-(2-(2-methyl-5-pyridyl)ethyl)-3,6-dimethyl-1,2,3,4-tetrahydro-.gamma.-carboline
75. 1227953-42-5
76. 1h-pyrido(4,3-b)indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridinyl)ethyl)-
77. 2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole
78. 2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole #
| Molecular Weight | 319.4 g/mol |
|---|---|
| Molecular Formula | C21H25N3 |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 21.1 |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 425 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
86
PharmaCompass offers a list of Latrepirdine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Latrepirdine manufacturer or Latrepirdine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Latrepirdine manufacturer or Latrepirdine supplier.
A Latrepirdine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Latrepirdine, including repackagers and relabelers. The FDA regulates Latrepirdine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Latrepirdine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Latrepirdine supplier is an individual or a company that provides Latrepirdine active pharmaceutical ingredient (API) or Latrepirdine finished formulations upon request. The Latrepirdine suppliers may include Latrepirdine API manufacturers, exporters, distributors and traders.
Latrepirdine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Latrepirdine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Latrepirdine GMP manufacturer or Latrepirdine GMP API supplier for your needs.
A Latrepirdine CoA (Certificate of Analysis) is a formal document that attests to Latrepirdine's compliance with Latrepirdine specifications and serves as a tool for batch-level quality control.
Latrepirdine CoA mostly includes findings from lab analyses of a specific batch. For each Latrepirdine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Latrepirdine may be tested according to a variety of international standards, such as European Pharmacopoeia (Latrepirdine EP), Latrepirdine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Latrepirdine USP).
